share_log

Bruker Analyst Ratings

Bruker Analyst Ratings

布鲁克分析师评级
Benzinga ·  2023/10/17 11:40
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
10/17/2023 3.78% JP Morgan $70 → $65 Maintains Neutral
05/05/2023 51.68% Citigroup $90 → $95 Maintains Buy
04/19/2023 11.77% Goldman Sachs $63 → $70 Maintains Sell
04/18/2023 11.77% Goldman Sachs $63 → $70 Maintains Sell
02/10/2023 43.7% Citigroup $80 → $90 Maintains Buy
10/21/2022 11.77% UBS → $70 Initiates Coverage On → Buy
08/22/2022 27.73% Citigroup $70 → $80 Upgrades Neutral → Buy
05/05/2022 38.91% SVB Leerink $85 → $87 Maintains Outperform
04/13/2022 -4.2% Goldman Sachs $73 → $60 Maintains Sell
02/14/2022 35.72% SVB Leerink $84 → $85 Maintains Outperform
11/02/2021 43.7% Wells Fargo $85 → $90 Maintains Equal-Weight
09/09/2021 59.67% SVB Leerink $90 → $100 Maintains Outperform
08/03/2021 35.72% Wells Fargo $70 → $85 Maintains Equal-Weight
06/18/2021 35.72% SVB Leerink $80 → $85 Maintains Outperform
06/15/2021 Cleveland Research Upgrades Neutral → Buy
02/05/2021 -12.18% Wells Fargo → $55 Downgrades Overweight → Equal-Weight
01/27/2021 11.77% SVB Leerink $50 → $70 Maintains Outperform
11/16/2020 Wolfe Research Upgrades Underperform → Peer Perform
08/04/2020 -24.96% Citigroup $38 → $47 Maintains Neutral
08/04/2020 -20.17% SVB Leerink $45 → $50 Maintains Outperform
07/20/2020 -21.76% B of A Securities $43 → $49 Maintains Buy
05/07/2020 -39.33% Citigroup $40 → $38 Maintains Neutral
05/07/2020 -32.94% Wells Fargo $50 → $42 Maintains Overweight
04/28/2020 -34.54% UBS $53 → $41 Maintains Neutral
04/02/2020 -44.12% Stifel $52 → $35 Maintains Hold
04/01/2020 Needham Downgrades Strong Buy → Hold
03/26/2020 -23.36% Barclays $52 → $48 Upgrades Equal-Weight → Overweight
03/20/2020 -36.13% Citigroup $52 → $40 Maintains Neutral
02/19/2020 0.59% Needham $62 → $63 Maintains Strong Buy
01/08/2020 -4.2% Wells Fargo → $60 Initiates Coverage On → Overweight
01/07/2020 -16.97% Citigroup → $52 Initiates Coverage On → Buy
11/15/2019 -15.38% Stifel → $53 Initiates Coverage On → Hold
09/26/2019 B of A Securities Upgrades Neutral → Buy
07/15/2019 -23.36% Goldman Sachs $32 → $48 Upgrades Sell → Neutral
05/03/2019 SVB Leerink Upgrades Market Perform → Outperform
04/12/2019 Deutsche Bank Upgrades → Buy
01/03/2019 -37.73% Needham → $39 Initiates Coverage On → Strong Buy
日期 上行/下行 分析公司 目标价格变化 评级变化 上一次/当前评级
10/17/2023 3.78% 摩根大通 $70→$65 维护 中性
05/05/2023 51.68% 花旗集团 $90→$95 维护
04/19/2023 11.77% 高盛 $63→$70 维护
04/18/2023 11.77% 高盛 $63→$70 维护
02/10/2023 43.7% 花旗集团 $80→$90 维护
2022年10月21日 11.77% 瑞银集团 →$70 开始承保 →购买
2022/08/22 27.73% 花旗集团 $70→$80 升级 中性→购买
05/05/2022 38.91% SVB Leerink $85→$87 维护 跑赢大盘
04/13/2022 -4.2% 高盛 $73→$60 维护
02/14/2022 35.72% SVB Leerink $84→$85 维护 跑赢大盘
11/02/2021 43.7% 富国银行 $85→$90 维护 等重
09/09/2021 59.67% SVB Leerink $90→$100 维护 跑赢大盘
08/03/2021 35.72% 富国银行 $70→$85 维护 等重
06/18/2021 35.72% SVB Leerink $80→$85 维护 跑赢大盘
2021/06/15 - 克利夫兰研究公司 升级 中性→购买
02/05/2021 -12.18% 富国银行 →$55 评级下调 超重→等重
2021/01/27 11.77% SVB Leerink $50→$70 维护 跑赢大盘
11/16/2020 - 沃尔夫研究 升级 表现不佳的→对等设备
08/04/2020 -24.96% 花旗集团 $38→$47 维护 中性
08/04/2020 -20.17% SVB Leerink $45→$50 维护 跑赢大盘
07/20/2020 -21.76% B of A证券 $43→$49 维护
05/07/2020 -39.33% 花旗集团 $40→$38 维护 中性
05/07/2020 -32.94% 富国银行 $50→$42 维护 超重
04/28/2020 -34.54% 瑞银集团 $53→$41 维护 中性
04/02/2020 -44.12% Stifel $52→$35 维护 保持
04/01/2020 - 李约瑟 评级下调 强力买入→Hold
03/26/2020 -23.36% 巴克莱 $52→$48 升级 等重→超重
03/20/2020 -36.13% 花旗集团 $52→$40 维护 中性
02/19/2020 0.59% 李约瑟 $62→$63 维护 强势购买
1/08/2020 -4.2% 富国银行 →$60 开始承保 →超重
1/07/2020 -16.97% 花旗集团 →$52 开始承保 →购买
2019年11月15日 -15.38% Stifel →$53 开始承保 →保留
2019年09月26日 - B of A证券 升级 中性→购买
2019年07月15日 -23.36% 高盛 $32→$48 升级 卖出→中性
2019年05月03日 - SVB Leerink 升级 市场表现优于→
2019年4月12日 - 德意志银行 升级 →购买
2019年03月01日 -37.73% 李约瑟 →$39 开始承保 →强势购买

What is the target price for Bruker (BRKR)?

布鲁克(Bruker)的目标价是多少?

The latest price target for Bruker (NASDAQ: BRKR) was reported by JP Morgan on October 17, 2023. The analyst firm set a price target for $65.00 expecting BRKR to rise to within 12 months (a possible 3.78% upside). 6 analyst firms have reported ratings in the last year.

摩根大通于2023年10月17日报道了布鲁克(纳斯达克代码:BRKR)的最新目标价。这家分析公司将目标价定为65.00美元,预计BRKR将在12个月内上涨(可能上涨3.78%)。6家分析公司在过去一年公布了评级。

What is the most recent analyst rating for Bruker (BRKR)?

布鲁克(BRKR)最近的分析师评级是多少?

The latest analyst rating for Bruker (NASDAQ: BRKR) was provided by JP Morgan, and Bruker maintained their neutral rating.

纳斯达克(Sequoia Capital:BRKR)的最新分析师评级由摩根大通提供,布鲁克维持中性评级。

When is the next analyst rating going to be posted or updated for Bruker (BRKR)?

布鲁克(Bruker)的下一次分析师评级将于何时发布或更新?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bruker, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bruker was filed on October 17, 2023 so you should expect the next rating to be made available sometime around October 17, 2024.

分析师在进行了广泛的研究后得出了股票评级,其中包括查阅公开财务报表,与布鲁克的高管和客户交谈,以及收听收益电话会议。大多数分析师每三个月就会这样做一次,所以你每年应该会得到每家公司每家公司的4个评级。布鲁克的上一次评级是在2023年10月17日提交的,所以你应该预计下一次评级将在2024年10月17日左右的某个时候公布。

Is the Analyst Rating Bruker (BRKR) correct?

分析师对布鲁克(BRKR)的评级正确吗?

While ratings are subjective and will change, the latest Bruker (BRKR) rating was a maintained with a price target of $70.00 to $65.00. The current price Bruker (BRKR) is trading at is $62.63, which is out of the analyst's predicted range.

虽然评级是主观的,并将发生变化,但最新的布鲁克(BRKR)评级维持不变,目标价在70.00美元至65.00美元之间。布鲁克目前的交易价格为62.63美元,超出了分析师的预测区间。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发